IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,884,711 | +99.7% | 454,619 | +23.5% | 0.01% | +50.0% |
| Q1 2023 | $8,955,776 | +988.1% | 368,096 | +857.5% | 0.00% | – |
| Q4 2022 | $823,044 | +34.0% | 38,442 | +12.3% | 0.00% | – |
| Q3 2022 | $614,000 | -53.9% | 34,246 | -75.3% | 0.00% | -100.0% |
| Q2 2022 | $1,333,000 | -69.1% | 138,575 | -46.0% | 0.00% | 0.0% |
| Q1 2022 | $4,319,000 | +95.5% | 256,600 | +94.2% | 0.00% | 0.0% |
| Q4 2021 | $2,209,000 | -71.5% | 132,101 | -72.4% | 0.00% | -66.7% |
| Q3 2021 | $7,760,000 | +3395.5% | 477,815 | +1255.5% | 0.00% | – |
| Q2 2021 | $222,000 | +93.0% | 35,250 | +89.6% | 0.00% | – |
| Q1 2021 | $115,000 | -89.0% | 18,594 | -87.7% | 0.00% | -100.0% |
| Q4 2020 | $1,046,000 | +566.2% | 151,388 | +392.2% | 0.00% | – |
| Q2 2020 | $157,000 | -21.5% | 30,755 | -47.1% | 0.00% | – |
| Q1 2020 | $200,000 | – | 58,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |